Intracellular uptake and behavior of two types zinc protoporphyrin (ZnPP) micelles, SMA-ZnPP and PEG-ZnPP as anticancer agents; Unique intracellular disintegration of SMA micelles

Journal of Controlled Release

Volumn 155, Issue 3, 2011, Pages 367-375

  Nakamura, Hideaki ^a   Fang, Jun ^a   Gahininath, Bharate ^a   Tsukigawa, Kenji ^a   Maeda, Hiroshi ^a  

^a SOJO UNIVERSITY   (Japan)

Author keywords

Anticancer micelles; HO 1 inhibitor; HSP32; PEG ZnPP; SMA ZnPP

Indexed keywords

ANTICANCER MICELLES; HO-1 INHIBITOR; HSP32; PEG-ZNPP; SMA-ZNPP;

GLYCOLS; MICELLES; MOLECULAR BIOLOGY; PHOSPHOLIPIDS; POLYETHYLENE OXIDES; PORPHYRINS; STYRENE; ZINC;

POLYETHYLENE GLYCOLS;

HEME OXYGENASE 1; MACROGOL; PHOSPHATIDYLCHOLINE; PROTOPORPHYRIN ZINC; ZINOSTATIN MALEIC ACID STYRENE COPOLYMER;

ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; HUMAN; HUMAN CELL; HYDROLYSIS; MICELLIZATION; PRIORITY JOURNAL; TUMOR CELL;

ANTINEOPLASTIC AGENTS; CELL CULTURE TECHNIQUES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG STABILITY; ENDOCYTOSIS; ENDOPLASMIC RETICULUM; HEME OXYGENASE-1; HUMANS; K562 CELLS; MALEATES; METALLOPORPHYRINS; MICELLES; MICROSCOPY, CONFOCAL; MICROSCOPY, FLUORESCENCE; POLYETHYLENE GLYCOLS; POLYSTYRENES; SOLUBILITY; SURFACE-ACTIVE AGENTS; ZINC;

EID: 80054695837     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2011.04.025     Document Type: Article

References (37)

1. S. Ishizawa, T. Yoshida, and G. Kikuchi Induction of heme oxygenase in rat liver. Increase of the specific mRNA by treatment with various chemicals and immunological identity of the enzymes in various tissues as well as the induced enzymes J. Biol. Chem. 258 7 1983 4220 4225 (Pubitemid 13080639)
2. R.K. Kutty, and M.D. Maines Effects of induction of heme oxygenase by cobalt and tin on the in vivo degradation of myoglobin Biochem. Pharmacol. 33 18 1984 2924 2926 (Pubitemid 14071039)
3. T.J. Smith, S. Haque, and G.S. Drummond Induction of heme oxygenase mRNA by cobalt protoporphyrin in rat liver Biochim. Biophys. Acta 1073 1 1991 221 224
4. K. Doi, T. Akaike, S. Fujii, S. Tanaka, N. Ikebe, T. Beppu, S. Shibahara, M. Ogawa, and H. Maeda Induction of haem oxygenase-1 nitric oxide and ischaemia in experimental solid tumours and implications for tumour growth Br. J. Cancer 80 12 1999 1945 1954 (Pubitemid 29391278)
5. J.H. Kaplan, and J.N. Groves Liver and blood cell catalase activity of tumor-bearing mice Cancer Res. 32 6 1972 1190 1194
6. A.M. Tarakhovskii, G.V. Glinskii, and V.A. Shliakhovenko Superoxide dismutase activity in tumor and liver of tumor-bearing animals Ukr. Biokhim. Zh. 52 5 1980 628 631
7. M. Mayerhofer, K.V. Gleixner, J. Mayerhofer, G. Hoermann, E. Jaeger, K.J. Aichberger, R.G. Ott, K. Greish, H. Nakamura, S. Derdak, P. Samorapoompichit, W.F. Pickl, V. Sexl, H. Esterbauer, I. Schwarzinger, C. Sillaber, H. Maeda, and P. Valent Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib Blood 111 4 2008 2200 2210 (Pubitemid 351451534)
8. J. Fang, T. Sawa, T. Akaike, T. Akuta, S.K. Sahoo, G. Khaled, A. Hamada, and H. Maeda In vivo antitumor activity of pegylated zinc protoporphyrin: targeted inhibition of heme oxygenase in solid tumor Cancer Res. 63 13 2003 3567 3574 (Pubitemid 36793037)
9. S.K. Sahoo, T. Sawa, J. Fang, S. Tanaka, Y. Miyamoto, T. Akaike, and H. Maeda Pegylated zinc protoporphyrin: a water-soluble heme oxygenase inhibitor with tumor-targeting capacity Bioconjug. Chem. 13 5 2002 1031 1038
10. H.W. Hwang, J.R. Lee, K.Y. Chou, C.S. Suen, M.J. Hwang, C. Chen, R.C. Shieh, and L.Y. Chau Oligomerization is crucial for the stability and function of heme oxygenase-1 in the endoplasmic reticulum J. Biol. Chem. 284 34 2009 22672 22679
11. A.K. Iyer, K. Greish, J. Fang, R. Murakami, and H. Maeda High-loading nanosized micelles of copoly(styrene-maleic acid)-zinc protoporphyrin for targeted delivery of a potent heme oxygenase inhibitor Biomaterials 28 10 2007 1871 1881 (Pubitemid 46123550)
12. K. Greish, A. Nagamitsu, J. Fang, and H. Maeda Copoly(styrene-maleic acid)-pirarubicin micelles: high tumor-targeting efficiency with little toxicity Bioconjug. Chem. 16 1 2005 230 236 (Pubitemid 40129698)
13. J. Fang, T. Sawa, T. Akaike, and H. Maeda Tumor-targeted delivery of polyethylene glycol-conjugated d-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide Cancer Res. 62 11 2002 3138 3143 (Pubitemid 34602406)
14. J.J. Shiah, Y. Sun, C.M. Peterson, and J. Kopecek Biodistribution of free and N-(2-hydroxypropyl)methacrylamide copolymer-bound mesochlorin e(6) and adriamycin in nude mice bearing human ovarian carcinoma OVCAR-3 xenografts J. Control. Release 61 1-2 1999 145 157 (Pubitemid 29406088)
15. Y. Matsumura, and H. Maeda A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs Cancer Res. 46 12 Pt 1 1986 6387 6392 (Pubitemid 17221789)
16. H. Maeda, T. Sawa, and T. Konno Mechanism of tumor-targeted delivery of macromolecular drugs, including the EPR effect in solid tumor and clinical overview of the prototype polymeric drug SMANCS J. Control. Release 74 1-3 2001 47 61 (Pubitemid 32727608)
17. H. Maeda Nitroglycerin enhances vascular blood flow and drug delivery in hypoxic tumor tissues: analogy between angina pectoris and solid tumors and enhancement of the EPR effect J Control Release 142 3 2010 296 298
18. H. Maeda, G.Y. Bharate, and J. Daruwalla Polymeric drugs for efficient tumor-targeted drug delivery based on EPR-effect Eur. J. Pharm. Biopharm. 71 3 2009 409 419
19. G. Gregoriadis, and E.D. Neerunjun Treatment of tumour bearing mice with liponsome-entrapped actinomycin D prolongs their survival Res. Commun. Chem. Pathol. Pharmacol. 10 2 1975 351 362
20. O. Hovorka, T. Etrych, V. Subr, J. Strohalm, K. Ulbrich, and B. Rihova HPMA based macromolecular therapeutics: internalization, intracellular pathway and cell death depend on the character of covalent bond between the drug and the peptidic spacer and also on spacer composition J. Drug Target. 14 6 2006 391 403 (Pubitemid 44203519)
21. K. Sasaki, K. Kogure, S. Chaki, Y. Kihira, M. Ueno, and H. Harashima Construction of a multifunctional envelope-type nano device by a SUV*-fusion method Int. J. Pharm. 296 1-2 2005 142 150 (Pubitemid 40693383)
22. C. Allen, Y. Yu, A. Eisenberg, and D. Maysinger Cellular internalization of PCL(20)-b-PEO(44) block copolymer micelles Biochim. Biophys. Acta 1421 1 1999 32 38 (Pubitemid 29421855)
23. P. Lemieux, M. Page, and C. Noel In vivo cytotoxicity and antineoplastic activity of a transferrin-daunorubicin conjugate In Vivo 6 6 1992 621 627
24. P. van der Sluijs, H.P. Bootsma, B. Postema, F. Moolenaar, and D.K. Meijer Drug targeting to the liver with lactosylated albumins: does the glycoprotein target the drug or is the drug targeting the glycoprotein? Hepatology 6 4 1986 723 728 (Pubitemid 16038196)
25. C.P. Leamon, I. Pastan, and P.S. Low Cytotoxicity of folate-Pseudomonas exotoxin conjugates toward tumor cells. Contribution of translocation domain J. Biol. Chem. 268 33 1993 24847 24854 (Pubitemid 23335500)
26. G.T. Colbern, D.J. Dykes, C. Engbers, R. Musterer, A. Hiller, E. Pegg, R. Saville, S. Weng, M. Luzzio, P. Uster, M. Amantea, and P.K. Working Encapsulation of the topoisomerase I inhibitor GL147211C in pegylated (STEALTH) liposomes: pharmacokinetics and antitumor activity in HT29 colon tumor xenografts Clin. Cancer Res. 4 12 1998 3077 3082 (Pubitemid 29001484)
27. Y. Matsumura, T. Oda, and H. Maeda General mechanism of intratumor accumulation of macromolecules: advantage of macromolecular therapeutics Gan To Kagaku Ryoho. 14 3 Pt 2 1987 821 829 (Pubitemid 17041105)
28. H. Maeda, J. Takeshita, and R. Kanamaru A lipophilic derivative of neocarzinostatin. A polymer conjugation of an antitumor protein antibiotic Int. J. Pept. Protein Res. 14 2 1979 81 87 (Pubitemid 9242619)
29. K.A. Nieforth, R. Nadeau, I.H. Patel, and D. Mould Use of an indirect pharmacodynamic stimulation model of MX protein induction to compare in vivo activity of interferon alfa-2a and a polyethylene glycol-modified derivative in healthy subjects Clin. Pharmacol. Ther. 59 6 1996 636 646 (Pubitemid 26233419)
30. T.M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau-Young Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 1 1991 29 36
31. H. Maeda, Tumor-selective delivery of macromolecular drugs via the EPR effect: background and future prospects. Bioconjug Chem 21(5) 797-802.
32. T. Masuda, H. Akita, K. Niikura, T. Nishio, M. Ukawa, K. Enoto, R. Danev, K. Nagayama, K. Ijiro, and H. Harashima Envelope-type lipid nanoparticles incorporating a short PEG-lipid conjugate for improved control of intracellular trafficking and transgene transcription Biomaterials 30 27 2009 4806 4814
33. H. Hatakeyama, H. Akita, K. Kogure, M. Oishi, Y. Nagasaki, Y. Kihira, M. Ueno, H. Kobayashi, H. Kikuchi, and H. Harashima Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid Gene Ther. 14 1 2007 68 77 (Pubitemid 44942867)
34. T. Oda, F. Sato, and H. Maeda Facilitated internalization of neocarzinostatin and its lipophilic polymer conjugate, SMANCS, into cytosol in acidic pH J Natl Cancer Inst 79 6 1987 1205 1211 (Pubitemid 18036723)
35. T. Oda, and H. Maeda Binding to and internalization by cultured cells of neocarzinostatin and enhancement of its actions by conjugation with lipophilic styrene-maleic acid copolymer Cancer Res. 47 12 1987 3206 3211 (Pubitemid 17082650)
36. M. Regehly, K. Greish, F. Rancan, H. Maeda, F. Bohm, and B. Roder Water-soluble polymer conjugates of ZnPP for photodynamic tumor therapy Bioconjug. Chem. 18 2 2007 494 499 (Pubitemid 46493521)
37. H. Xu, Y. Deng, D. Chen, W. Hong, Y. Lu, and X. Dong Esterase-catalyzed dePEGylation of pH-sensitive vesicles modified with cleavable PEG-lipid derivatives J. Control. Release 130 3 2008 238 245